Achieving the goal of vaccinating 10 to 20 percent of the city is still a far way off. ICAP’s Wafaa El-Sadr, MD, MPH, MPA, is concerned that despite months to prepare, there still seemed to be a steep learning curve when it comes to “the nitty-gritty of how do you get it from the freezer to the arm as quickly as possible,” she said. “I think there are growing pains as people are picking up how to do this.”
Read the full article in The New York Times.
Read the latest ICAP updates on COVID-19 here
A major global health organization that has been improving public health in countries around the world for over 15 years, ICAP works to transform the health of populations through innovation, science, and global collaboration. Based at Columbia University in New York City, where it is part of the Mailman School of Public Health, ICAP has projects in more than 30 countries, working side-by-side with ministries of health and local partners to confront some of the world’s toughest health challenges. Through meaningful research, tailored technical assistance, effective training and education programs, and rigorous surveillance to measure and evaluate the impact of public health interventions, ICAP aims to realize a global vision of healthy people, empowered communities, and thriving societies. Online at icap.columbia.edu
